Oral IIa and Xa Inhibitors for Prevention of Stroke in Atrial Fibrillation: Clinical Studies and Regulatory Considerations

Spyridon Deftereos, Dimitrios Tsounis, Georgios Giannopoulos, Charalampos Kossyvakis, Vasiliki Panagopoulou, Konstantinos Raisakis, Christodoulos Stefanadis
  • Current Clinical Pharmacology, June 2012, Bentham Science Publishers
  • DOI: 10.2174/157488412800958749
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Georgios Giannopoulos

In partnership with: